Skip to main content
Log in

A Questionnaire Study to Assess Long-Term Outcome in Patients with Abnormal Esophageal Manometry

  • Published:
Dysphagia Aims and scope Submit manuscript

Abstract

Patients with unexplained chest pain or dysphagia are often referred for esophageal manometric studies to further investigate their symptoms. Four main manometric abnormalities have been described: achalasia, diffuse esophageal spasm, “nutcracker” (hypercontracting) esophagus, and hypocontracting esophagus. With the exception of achalasia, treatments are of limited benefit and the natural history of these conditions is largely unknown. We sent questionnaires to patients who were investigated at least three years before our study began. They repeated a DeMeester symptom questionnaire that they had completed at the time of their initial study. Questionnaires were sent to 137 patients with diffuse esophageal spasm, “nutcracker” (hypercontracting) esophagus, or hypocontracting esophagus. We also sent questionnaires to 57 patients with dysphagia or chest pain who had had normal esophageal manometry and pH studies. These patients acted as symptomatic controls. Responses were compared using the Wilcoxon signed ranks test. Seventy-two (53%) patients with diffuse esophageal spasm, “nutcracker” esophagus, or hypocontracting esophagus replied. An additional 8 (6%) patients died. Symptom scores in all three conditions had improved significantly over time (p ≤ 0.01 for each condition, Wilcoxon signed ranks test). Patients with dysphagia or chest pain but normal esophageal studies had not improved. The significance of diffuse esophageal spasm, “nutcracker” esophagus, and hypocontracting esophagus found at esophageal manometry remains uncertain. Although treatment is often ineffective, these conditions typically run a benign course. Patients can be reassured that their symptoms are likely to improve with time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Dekel R, Pearson T, Wendel C, De Garmo P, Fennerty MB, Fass R: Assessment of esophageal motor function in patients with dysphagia or chest pain—the Clinical Outcomes Research Initiative experience. Aliment Pharmacol Ther 18:1083–1089, 2003

    Article  PubMed  CAS  Google Scholar 

  2. McLauchlan G: Esophageal function testing and antireflux surgery [review]. Br J Surg 83:1684–1688, 1996

    Article  PubMed  CAS  Google Scholar 

  3. Willis T: Pharmaceutice Rationalis sive Diatriba do Medicamentorum Operationibus in Humano Corpore. London: Hagae Comitis, 1674

    Google Scholar 

  4. Spechler SJ, Castell DO: Classification of esophageal abnormalities. Gut 49:145–151, 2001

    Google Scholar 

  5. Richter J: Esophageal motility disorders. Lancet 358:823–828, 2001

    Article  PubMed  CAS  Google Scholar 

  6. Osgood H: A peculiar form of esophagismus. Boston Med Surg J 120:401–403, 1889

    Google Scholar 

  7. Penagini R, Bartesaghi B, Bianchi PA: Importance of esophageal manometry in the diagnosis of esophageal motility disorders. Report of two cases. Panminerva Med 34:81–84, 1992

    PubMed  CAS  Google Scholar 

  8. Hewson EG, Dalton CB, Hackshaw BT, Wu WC, Richter JE: The prevalence of abnormal esophageal test results in patients with cardiovascular disease and unexplained chest pain. Arch Intern Med 150:965–969, 1990

    Article  PubMed  CAS  Google Scholar 

  9. Richter JE, Dalton CB, Buice RG, Castell DO: Nifedipine: a potent inhibitor of contractions in the body of the human esophagus. Studies in healthy volunteers and patients with the nutcracker esophagus. Gastroenterology 89:549–554, 1995

    Google Scholar 

  10. Richter J, Dalton C, Bradley L, Castell DO: Oral nifedipine in the treatment of noncardiac chest pain in patients with the nutcracker esophagus. Gastroenterology 93:21–28, 1987

    PubMed  CAS  Google Scholar 

  11. Narducci F, Bassotti G, Gaburri M, Morelli A: Transition from nutcracker esophagus to diffuse esophageal spasm. Am J Gastroenterol 80:242–244, 1985

    PubMed  CAS  Google Scholar 

  12. Robson K, Rosenberg S, Lembo T: GERD progressing to diffuse esophageal spasm and then to achalasia. Dig Dis Sci 45:110–113, 2000

    Article  PubMed  CAS  Google Scholar 

  13. DeMeester TR, Wang CI, Wernly JA, Pellegrini CA, Little AG, Klementschitsch P, Bermudez G, Johnson LF, Skinner DB: Technique, indications, and clinical use of 24 hour esophageal pH monitoring. J Thorac Cardiovasc Surg 79:656–670, 1980

    PubMed  CAS  Google Scholar 

  14. DeMeester TR, Lafontaine E, Joelsson BE, Skinner DB, Ryan JW, O’Sullivan GC, Brunsden BS, Johnson LF: Relationship of a hiatal hernia to the function of the body of the esophagus and the gastresophageal junction. J Thorac Cardiovasc Surg 82: 547–558, 1981

    PubMed  CAS  Google Scholar 

  15. McDougall NI, Johnston BT, Kee F, Collins JS, McFarland RJ, Love AH: Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life. Gut 38:481–486, 1996

    Article  PubMed  CAS  Google Scholar 

  16. Rowley H, O’Dwyer TP, Jones AS, Timon CI: The natural history of globus pharyngeus. Laryngoscope 105:1118–1121, 1995

    Article  PubMed  CAS  Google Scholar 

  17. Ward BW, Wu WC, Richter JE, Hackshaw BT, Castell DO: Long-term follow-up of symptomatic status of patients with noncardiac chest pain: is diagnosis of esophageal etiology helpful? Am J Gastroenterol 82:215–218, 1987

    PubMed  CAS  Google Scholar 

  18. Silva LF, Lemme EM: Nutcracker esophagus: clinical evaluation of 97 patients. Arq Gastroenterol 37:217–223, 2000 [in Portuguese]

    Article  PubMed  CAS  Google Scholar 

  19. Barreca M, Oelschlager BK, Pellegrini CA: Outcomes of laparoscopic Nissen fundoplication in patients with the “hypercontractile esophagus.” Arch Surg 137:724–728, 2002

    Article  PubMed  Google Scholar 

  20. Nastos D, Chen LQ, Ferraro P, Taillefer R, Duranceau AC: Long myotomy with antireflux repair for esophageal spastic disorders. J Gastrointest Surg 6:713–722, 2002

    Article  PubMed  Google Scholar 

  21. Borjesson M, Rolny P, Mannheimer C, Pilhall M: Nutcracker esophagus: a double-blind, placebo-controlled, cross-over study of the effects of lansoprazole. Aliment Pharmacol Ther 18:1129–1135, 2003

    Article  PubMed  CAS  Google Scholar 

  22. Gockel I, Lord RV, Bremner CG, Crookes PF, Hamrah P, DeMeester TR: The hypertensive lower esophageal sphincter: a motility disorder with manometric features of outflow obstruction. J Gastrointest Surg 7:692–700, 2003

    Article  PubMed  Google Scholar 

  23. Tamhankar AP, Almogy G, Arain MA, Portale G, Hagen JA, Peters JH, Crookes PF, Sillin LF, DeMeester SR, Bremner CG, DeMeester TR: Surgical management of hypertensive lower esophageal sphincter with dysphagia or chest pain. J Gastrointest Surg 7:990–996, 2003

    Article  PubMed  Google Scholar 

  24. Lee JI, Park H, Kim JH, Lee SI, Conklin JL: The effect of sildenafil on esophageal motor function in healthy subjects and patients with nutcracker esophagus. Neurogastroenterol Motil 15:617–623, 2003

    Article  PubMed  CAS  Google Scholar 

  25. Cattau EL Jr, Castell DO, Johnson DA, Spurling TJ, Hirszel R, Chobanian SJ, Richter JE: Diltiazem therapy for symptoms associated with nutcracker esophagus. Am J Gastroenterol 86:272–276, 1991

    PubMed  Google Scholar 

  26. Pimentel M, Bonorris GG, Chow EJ, Lin HC: Peppermint oil improves the manometric findings in diffuse esophageal spasm. J Clin Gastroenterol 33:27–31, 2001

    Article  PubMed  CAS  Google Scholar 

  27. Storr M, Allescher HD, Rosch T, Born P, Weigert N, Classen M: Treatment of symptomatic diffuse esophageal spasm by endoscopic injections of botulinum toxin: a prospective study with long-term follow-up. Gastrointest Endosc 54:754–759, 2001

    Article  PubMed  CAS  Google Scholar 

  28. Handa M, Mine K, Yamamoto H, Hayashi H, Tsuchida O, Kanazawa F, Kubo C: Antidepressant treatment of patients with diffuse esophageal spasm: a psychosomatic approach. J Clin Gastroenterol 28:228–232, 1999

    Article  PubMed  CAS  Google Scholar 

  29. Clouse RE, Lustman PJ, Eckert TC, Ferney DM, Griffith LS: Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo-controlled trial. Gastroenterology 92:1027–1036, 1987

    PubMed  CAS  Google Scholar 

  30. Blom D, Peters JH, DeMeester TR, Crookes PF, Hagan JA, DeMeester SR, Bremner C: Physiologic mechanism and preoperative prediction of new-onset dysphagia after laparoscopic Nissen fundoplication J Gastrointest Surg 6:22–27, 2002

    Article  PubMed  Google Scholar 

  31. Harewood GC, Yacavone RF, Locke GR 3rd, Wiersema MJ: Prospective comparison of endoscopy patient satisfaction surveys: e-mail versus standard mail versus telephone. Am J Gastroenterol 96:3312–3317, 2001

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H.L. Spencer MA, MBBS, MRCP.

Appendices

Appendix 1. Classification of Primary Esophageal Motility Disorders [4,5]

  • Achalasia

  • Absent distal peristalsis

  • Abnormal lower esophageal sphincter (LES) relaxation

  • Can have raised LES pressure (>45 mmHg)

  • Diffuse Esophageal Spasm

  • Simultaneous contractions 20% or more of wet swallows

  • Intermittent peristalsis

  • Can have repetitive or multipeak contractions (3 or more peaks)

  • Can have spontaneous contractions not associated with swallows

  • Contraction amplitude > 30 mmHg but usually not high amplitude

  • Hypercontracting Esophagus

  • Hypertensive esophagus—“nutcracker”

  • Increased mean distal amplitude (>180 mmHg)

  • Normal peristalsis

  • Can be of increased distal duration (>6 seconds)

  • Hypertensive LES

  • Resting LES pressure > 45 mmHg

  • May be incomplete LES relaxation

  • Hypocontracting Esophagus

  • Ineffective esophageal motility

  • 30% or more, low distal amplitude (<30 mmHg) or failed nontransmitted contractions

  • Hypotensive LES

  • Resting LES pressure <10 mmHg

Appendix 2. Modified DeMeester Questionnaire

  • Heartburn?

  • 0 - None

  • 1 - Minimal

  • 2 - Moderate

  • 3 - Severe

  • Regurgitation ?

  • 0 - None

  • 1 - Minimal

  • 2 - Moderate

  • 3 - Severe

  • Vomiting?

  • 0 - None

  • 1 - Rarely

  • 2 - Moderately severe

  • 3 - Severe

  • Difficulty swallowing (things getting stuck)?

  • 0 - None

  • 1 - Coarse foods only (e.g., chunks of bread)

  • 2 - Solid foods

  • 3 - Either: - liquids, or lasting for more than 5 minutes, or with associated pain

  • Indigestion?

  • 0 - None

  • 1 - Mild abdominal pain or flatulence (wind)

  • 2 - Troublesome abdominal pain or excess flatulence or excess salivation

  • 3 - Very severe

  • Night-time symptoms?

  • 0 - None

  • 2 - Any symptom that wakes you up

  • Minimum score = 0; Maximum score = 17

Appendix 3. Supplementary Questions Asked in Mailed Questionnaire

  1. 1.

    Compared with how you were when you were investigated at Northern General Hospital with the esophageal manometry study, would you say that the symptoms you were investigated for are: -

    • Better □ The same □ Worse □

  2. 2.

    How often do these symptoms occur compared with when you were investigated?

    • More □ About as often □ Less □

  3. 3.

    How do these symptoms affect your quality of life?

    • A little □ A lot □ Not at all □

  4. 4.

    Did you find the explanation of the results of your manometry study affected how you coped with your symptoms?

    • Helpful □ Not helpful □

  5. 5.

    What medicine (if any) have you found most helpful over the years at controlling these symptoms?

  6. 6.

    What single thing (medicine or otherwise) do you think has been the most useful over the years in helping to control these symptoms?

  7. 7.

    Do you currently suffer with chest pain?

    • □ -None □ - Minimal □ - Moderate □ - Severe

  • Please list all your current medication, stating doses if possible ........................................................................... ..........................................................................

  • Do you drink alcohol?................. If so, how much per week?

  • Do you smoke?.................. If so, how many per day?

  • Do you drink tea or coffee?.................. How many mugs/cups per day?

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spencer, H., Smith, L. & Riley, S. A Questionnaire Study to Assess Long-Term Outcome in Patients with Abnormal Esophageal Manometry. Dysphagia 21, 149–155 (2006). https://doi.org/10.1007/s00455-006-9022-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00455-006-9022-y

Keywords

Navigation